Novavax partners secure Nuvaxovid approvals for 2026-2027 season
XFG-adapted COVID-19 vaccine has been approved in the U.S., European Union and Japan.
Novavax
FDA approves 2025-2026 version of Novavax COVID-19 Vaccine
Nuvaxovid's approval comes as officials prepare for another vaccination season, with manufacturers updating their shots to target circulating variants.